Effect of lysolecithin and analogs on mouse ascites tumors.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy* / Q000401:mortality; D004305:Dose-Response Relationship, Drug; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy / Q000401:mortality; D008244:Lysophosphatidylcholines / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000188:drug therapy* / Q000401:mortality; D012967:Sodium Dodecyl Sulfate / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000627:therapeutic use; D013997:Time Factors
D008244:Lysophosphatidylcholines; D013501:Surface-Active Agents; D012967:Sodium Dodecyl Sulfate